SCHEMBL230460

SCHEMBL230460

Cc1ccc2cccc(N)c2n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 1/20 0.59
CCR1 P32246 1/20 0.58
RAB9A P51151 1/20 0.58
CCR5 P51681 1/20 0.58
PARP1 P09874 1/20 0.55
KDM4E B2RXH2 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
SLC40A1 Q9NP59 3/20 0.53
NFKBIA P25963 1/20 0.53
RELA Q04206 1/20 0.53
HTR3A P46098 1/20 0.49
GLO1 Q04760 2/20 0.47
NOS3 P29474 1/20 0.46
NOS2 P35228 1/20 0.46
CYP1A2 P05177 1/20 0.45
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
AGTR1 P30556 1/20 0.42
PAX8 Q06710 1/20 0.42
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27786392 1.00 METAP2 (0.59) METAP2CCR1RAB9ACCR5PARP1
SCHEMBL28013759 0.98 METAP2 (0.57) METAP2CCR1RAB9ACCR5PARP1
Hydrochloric Acid SCHEMBL3585581 0.98 METAP2 (0.57) METAP2CCR1RAB9ACCR5PARP1
8-Aminoquinoline SCHEMBL29005897 0.89 LMNA (0.56) METAP2CCR1RAB9ACCR5PARP1
SCHEMBL11889685 0.83 CCR1 (0.57) METAP2CCR1RAB9ACCR5PARP1
SCHEMBL21975961 0.77 NCF1 (0.63) HTR3ANOS2
SCHEMBL806441 0.77 CCR1 (0.64) METAP2CCR1RAB9ACCR5PARP1
SCHEMBL2115749 0.77 CCR1 (0.64) METAP2CCR1RAB9ACCR5PARP1
SCHEMBL7453433 0.76 CCR1 (0.61) METAP2CCR1RAB9ACCR5PARP1
SCHEMBL27782197 0.76 CCR1 (0.61) METAP2CCR1RAB9ACCR5PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 684 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118666770-A Chiral tridentate anionic ligand containing oxazoline fragment and synthesis method and application thereof 武汉理工大学 2024-09-20 CN claimed
CN-118221661-A Squaric acid amide fluorescent probe based on thiophenyl quinoline for identifying adenosine triphosphate and preparation method thereof 常州大学 2024-06-21 CN claimed
CN-117447517-A Novel tridentate pincer ligand, ruthenium complex, preparation method thereof and application thereof in alcohol dehydrogenation preparation of ester 中国科学院宁波材料技术与工程研究所 2024-01-26 CN claimed
CN-117430484-A Polyester hydrogenation degradation method 中国科学院宁波材料技术与工程研究所 2024-01-23 CN claimed
CN-117362329-A Preparation method and application of NNO tridentate coordination metal catalyst based on quinoline skeleton 青岛科技大学 2024-01-09 CN claimed
CN-113462188-B Pigment yellow 138 easy to disperse in weak solvent and preparation method thereof 潍坊泰兴生物化工有限责任公司 2023-12-01 CN claimed
CN-116726997-A Preparation method of amino acid functionalized column [5] aromatic hydrocarbon supermolecule chiral catalyst 广西大学 2023-09-12 CN claimed
CN-113881242-B Preparation method of pigment yellow PY138 product with low yield value for iron printing ink 潍坊泰兴生物化工有限责任公司 2023-07-18 CN claimed
CN-115850337-A Tridentate pincerlike manganese complex, preparation method thereof and application thereof in alcohol dehydro-olefination reaction 中国科学院宁波材料技术与工程研究所 2023-03-28 CN claimed
CN-110105337-B Quinoline triarylamine and preparation method thereof 湖南大学 2022-12-23 CN claimed
US-20060189604-A1 Compounds GLAXO GROUP LIMITED (GB) 2006-08-24 US claimed
CN-1763013-A 8-amidoquinaldine production method GAOYOU AUX Y FACTORY (CN) 2006-04-26 CN claimed
WO-2006032466-A2 NEW BICYCLIC ANTIBIOTICS ACTELION PHARMACEUTICALS LTD (CH) 2006-03-30 WO claimed
US-20050234108-A1 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-10-20 US claimed
EP-1537123-A1 COMPOUNDS GLAXO GROUP LIMITED (GB) 2005-06-08 EP claimed
WO-2004002992-A1 COMPOUNDS GLAXO GROUP LIMITED (GB) 2004-01-08 WO claimed
US-6121452-A REACTING A NITROGEN-CONTAINING HETEROCYCLIC COMPOUND WITH AN AROMATIC DICARBOXYLIC ACID OR AN ANHYDRIDE THEREOF IN AN ORGANIC SOLVENT IN THE PRESENCE OF AN UNSUBSTITUTED PHENOL OR NAPHTHOL OR MIXTURE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2000-09-19 US claimed
US-5342950-A Reacting a methyl-substituted heterocyclic compound with an anhydride of an aromatic dicarboxylic acid in an alkyl benzoate solvent BASF AKTIENGESELLSCHAFT (DE) 1994-08-30 US claimed
EP-0463477-B1 Method of preparation of quinophthalones BASF AG (DE) 1994-03-16 EP claimed
US-5106980-A PREPARATION OF QUINOPHTHALONES BASF AKTIENGESELLSCHAFT (DE) 1992-04-21 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234108-A1 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions DPP8, DPP4, DPP7 METAP2 30/4885CCR1 911/4885RAB9A 2916/4885
US-20060189604-A1 Compounds ELANE, PIGS, SDHA METAP2 3046/4885CCR1 73/4885RAB9A 3294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.